Letrozol Kern Pharma 2
Sponsors
Medica Scientia Innovation Research S.L.
Conditions
HER2- positive breast cancerStudy to evaluate the effect of metformin in the prevention of hyperglycemia
in HR[+]/HER2[–] PIK3CA-mutated advanced breast cancer patients treated
with alpelisib plus endocrine therapy. The Metallica study.
Phase 2
Study to evaluate the effect of metformin in the prevention of hyperglycemia
in HR[+]/HER2[–] PIK3CA-mutated advanced breast cancer patients treated
with alpelisib plus endocrine therapy. The Metallica study.
CompletedCTIS2024-511295-33-00
Start: 2020-08-13End: 2025-03-16Target: 88Updated: 2025-02-03
Chemotherapy-free trastuzumab and pertuzumab in HER2-positive breast cancer: FDG-PET response-adapted strategy
The PHERGain study.
Active, not recruitingCTIS2023-509923-42-00
Start: 2017-07-06Target: 345Updated: 2025-11-25